News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
Biotech/Pharma - Mergers and Acquisitions (World)
DrugDev Acquires Award-Winning Trialnetworks Platform, Launches Innovation Lab, Unveils Investigator Databank Website And Reaches $1 Billion In Global Site Payments In First Half Of 2014 8/21/2014
Pfizer Inc. (PFE) Eyes Possible Actavis (ACT) Bid Whilst Weighing Next Steps Over AstraZeneca PLC (AZN) 8/21/2014
Mylan Inc. (MYL) Makes Second Round Of Bidding For GlaxoSmithKline (GSK) Drug Portfolio 8/21/2014
Sweden's Recipharm AB Pays $160 Million For Corvette Pharmaceutical Services Group 8/19/2014
Confirmed: Novartis AG (NVS) To Invest In Gamida Cell Ltd., Could Buy Out Company In $635 Million Cancer Deal 8/19/2014
Conflicting Reports Surface Over Roche Holding AG (RHHBF.PK)'s $10 Billion Deal, Chugai Pharmaceutical Co., Ltd. (Japan) Denies Talks 8/19/2014
Deal Is Back On: Novartis AG (NVS) To Invest Heavily In Gamida Cell Ltd. Before Acquisition 8/18/2014
InterMune, Inc. (ITMN) Goes Up On The Block; GlaxoSmithKline (GSK), Roche (RHHBY), Sanofi (France) (SAN.PA) Line Up 8/18/2014
Mallinckrodt Pharmaceuticals (MNK) Completes Acquisition Of Questcor Pharmaceuticals, Inc. (QCOR) 8/15/2014
Roche (RHHBY) May Gobble Up The Rest Of Chugai Pharmaceutical Co., Ltd. (Japan) For $10 Billion 8/15/2014
Merck KGaA (MKGAF.PK) CEO Eyes Interesting Takeover Targets 8/14/2014
Miltenyi Biotec, Inc. Acquires Gene Therapy Assets From Lentigen Corporation 8/14/2014
SkyePharma Inc. (SKYE) Acquires A Novel Inhaled Therapy Platform 8/13/2014
uniQure Acquires Cardiology Gene Therapy Company InoCard 8/12/2014
Boehringer Ingelheim Vetmedica, Inc. Acquires Licensing Rights For Artilysin® Technology From Lysando AG 8/12/2014
AstraZeneca PLC (AZN), Shire Slip As The U.S. Looks To Stop Tax Inversion Deals 8/7/2014
After Layoff News, Novartis AG (NVS)'s New York Campus Officially Goes On The Market 8/7/2014
Endo International plc (ENDP) Completes Acquisition Of DAVA Pharmaceuticals 8/7/2014
Analysts Believe Vulnerable GlaxoSmithKline (GSK) May Be Pfizer Inc. (PFE)'s Plan B 8/6/2014
Roche (RHHBY) Bags Santaris Pharma A/S In Deal Worth $450 Million 8/5/2014
Private Equity Firms Mull $10 Billion Merger Of Older GlaxoSmithKline (GSK), Sanofi (France) (SAN.PA) Brands 8/4/2014
Hedge Funds Bet AstraZeneca PLC (AZN) Will Stay Independent For A Little While Longer 8/4/2014
Meda AB (MEDA-A.ST) Bags Rottapharm $3.08 Billion To Create A European Pharma Powerhouse 7/31/2014
Pfizer Inc. (PFE)’s Stake In Cellectis (ALCLS)’ Capital Is Welcomed By Its Shareholders 7/31/2014
AstraZeneca PLC (AZN) Scoops Up Almirall Lung Drugs For Up To $2.1 Billion 7/30/2014
Pfizer Inc. (PFE) CEO Aggressively Seeking Deals, Leaves Investors Guessing On AstraZeneca PLC (AZN) Intentions 7/30/2014
Cellectis (ALCLS) Sells Its Swedish Unit To Takara Bio For Undisclosed Amount 7/29/2014
AbbVie (ABBV) Trod Cautiously In Inversion Takeover Bid To Woo Drug Maker Shire 7/25/2014
Hikma Pharmaceuticals Buys Ben Venue Laboratories's Generic Manufacturing Site 7/24/2014
Stallergenes, S.A. (GENP.PA) Expands Latin American Presence With Acquisition Of Alergo Pharma S.R.L. In Argentina 7/21/2014
Roche (RHHBY) CEO Plans To Steer Clear Of Big Acquisitions 7/21/2014
Novartis AG (NVS), BWK Sell Stakes In Patch Maker LTS Lohmann Therapie-Systeme AG, Pockets $400 Million From Sale 7/17/2014
Sanofi (France) (SAN.PA) Quietly Held Talks With Abbott Laboratories (ABT), Mylan Inc. (MYL) About Mature Drugs 7/17/2014
Yibai Pharma To Acquire Horus C&K Pharma For $128 Million 7/16/2014
Chiltern Acquires Ockham And The Companies Merge Operations 7/15/2014
Phlexglobal Announces Acquisition By Bridgepoint Development Capital 7/15/2014
Hikma Pharmaceuticals Completes The Acquisition Of Assets Of Bedford Laboratories 7/15/2014
BioTie Therapies Corp. Will Not Exercise Option To Buy Neurelis, Neurelis Regains Rights To Intranasal Diazepam Program 7/11/2014
Valeant Pharmaceuticals International (VRX) Completes Sale Of Filler And Toxin Assets To Galderma 7/10/2014
AbbVie (ABBV) Forced To Retract Claims Of Shire Investor Support 7/9/2014
Salix Pharmaceuticals, Ltd. (SLXP) Scoops Up Cosmo Technologies For Tax Savings 7/9/2014
$100 Million Triple Life Sciences Deal For Newly Formed Concept Life Sciences 7/8/2014
AbbVie (ABBV)'s Battle For Shire: Why This Time It's Different 7/8/2014
Valeant Pharmaceuticals International (VRX) Completes Acquisition Of PreCision Dermatology 7/8/2014
Xellia Pharmaceuticals Expands Into The U.S. With Manufacturing Plant Buy 7/7/2014
Jazz Pharmaceuticals plc (JAZZ) Wagers Up To $250 Million On Rare Disease Drug From Sigma-Tau Pharmaceuticals 7/3/2014
Medicure Inc. (MCU) Grabs Minority Position In Pharmaceutical Manufacturer, Apicore LLC 7/3/2014
NicOx SA (COX.PA) Scoops Up Aciex Therapeutics In $120 Million Deal 7/2/2014
Cell Source Inc. Announces Acquisition And $3.6 Million Private Placement To Advance Novel Cancer Therapies 7/1/2014
AbbVie (ABBV) Takes Shire Courtship Trip To London 6/30/2014
Merz North America Pays $600 Million For Ultrasound Facelift Company Ulthera 6/30/2014
RedHill Biopharma Ltd. (RDHL) Acquires Phase 2 Oncology Drug MESUPRON® From Wilex AG (WL6.DE) 6/30/2014
Shire Entertained Many "Large Opportunities" Before AbbVie (ABBV) Bid 6/27/2014
Like GlaxoSmithKline (GSK), Sanofi (France) (SAN.PA) Mulls Sale Of Older Drugs, Plans To Put Dengue Vaccine Program In Separate Unit 6/27/2014
AbbVie (ABBV) Urges Talks With Shire, May Have To Raise Bid To $51 Billion 6/25/2014
Valeant Pharmaceuticals International (VRX) Files Preliminary Proxy Statement For Special Meeting Of Shareholders To Approve Share Issuance In Proposed Acquisition Of Allergan Inc. (AGN) 6/25/2014
Warnex Inc. (CC:WNX) Received TSX-V Approval And Waives Due Diligence Condition To Amalgamation With Diagnos Inc. (ADK) 6/25/2014
Shire To Set Out AstraZeneca PLC (AZN)-Style Defense Against AbbVie (ABBV)'s $46 Billion Bid 6/24/2014
Endo Buys DAVA Pharmaceuticals For $575 Million 6/24/2014
H. Lundbeck A/S (LUN.CO) Completes Acquisition Of Chelsea Therapeutics, Inc. (CHTP) 6/24/2014
Actavis (ACT) And Forest Laboratories, Inc. (FRX) Announce Tentative Election Deadline Of June 27, 2014 6/24/2014
Abbott Laboratories (ABT) Scoops Up Russian Drugmaker Veropharm For Between $395 To $495 Million Cash 6/24/2014
AbbVie (ABBV) Release: Shire Bid Could Move A Lot High Risk Puts Ceiling At £55/Share 6/23/2014
Lundbeck Inc. (LUN.CO) Successfully Completes Tender Offer For Chelsea Therapeutics, Inc. (CHTP) 6/23/2014
Shire plc Release: Management Spurns Three Offers From AbbVie (ABBV) , Fighting For Irish Independence, Call Monday Morning 6/23/2014
To Fend Off Pfizer Inc. (PFE), AstraZeneca PLC (AZN) Contemplating Sale Of Some Future Revenue From Existing Drugs 6/23/2014
Third Time Is Not The Charm As AbbVie (ABBV)'s $46 Billion Bid For Irish Rival Shire Rejected 6/23/2014
Rumor: Pfizer Inc. (PFE) May Be Interested In Buying Bristol-Myers Squibb Company (BMY) After Losing AstraZeneca PLC (AZN) 6/20/2014
While Valeant Pharmaceuticals International (VRX) Fights For Allergan Inc. (AGN), Allergan Takeover Bid For Shire "Imminent" 6/19/2014
New Drugs To Help Maintain Independence, Ward Off M&A Prospects: Actelion Ltd. (ALIOF.PK) CEO 6/19/2014
Trendlines Acquires Intellectual Property From Collaboration With Endo 6/18/2014
Irish-Based Shire Braces For Takeover Bids 6/18/2014
Pfizer Inc. (PFE) CFO Reveals Money Killed AstraZeneca PLC (AZN) Deal 6/16/2014
Commentary: BioSpace (DHX) Readers Sound Off On Big Pharma Takeovers 6/12/2014
Roche (RHHBY) Markets 5 Buildings On New Jersey Campus, Razing The Rest 6/11/2014
Chelsea Therapeutics, Inc. (CHTP) Announces The Expiration Of The Hart-Scott-Rodino Waiting Period In Relation To The Proposed Acquisition Of Chelsea Therapeutics By H. Lundbeck A/S (LUN.CO) 6/6/2014
Teva Pharmaceutical Industries Limited (TEVA) Buys Privately Held Labrys Biologics In Deal Worth $825 Million 6/4/2014
GlaxoSmithKline (GSK) Hunts For Suitors To Buy Older Drugs, Eyes Cash To Focus On Most Lucrative Areas Of Business 6/2/2014
Endo Completes Sale Of Early Stage Drug Discovery Portfolio 6/2/2014
TiGenix Completes The Sale Of Its Dutch Manufacturing Facility To PharmaCell BV 6/2/2014
Provence Technologies Acquires Synprosis 6/2/2014
Pfizer Inc. (PFE) Officially Ditches Pursuit Of AstraZeneca PLC (AZN) 5/29/2014
Sweden's Lund University Acquires Biomass Pretreatment Reactor From AdvanceBio Systems 5/27/2014
Recordati S.p.A Finalizes The Second Tranche Of Its Acquisition Of Opalia Pharma In Tunisia 5/27/2014
Loophole Offers Pfizer Inc. (PFE) A Risky Way Back Into A Deal With AstraZeneca PLC (AZN) 5/23/2014
H. Lundbeck A/S (LUN.CO) Commences Tender Offer For All Outstanding Shares Of Chelsea Therapeutics, Inc. (CHTP) 5/23/2014
BioAlliance Pharma, TopoTarget A/S To Merge, Combined Entity To Be Named Onxeo 5/22/2014
Clarification Regarding Pfizer Inc. (PFE) Statement 5/21/2014
AstraZeneca PLC (AZN) Rejects Pfizer Inc. (PFE)'s Final Offer 5/20/2014
Endo Completes Acquisition Of Rights To Sumavel® DosePro® 5/19/2014
Boston Scientific Corporation (BSX) Pays $415 Million For Bayer AG (BAYZF) Unit 5/19/2014
Abbott Laboratories (ABT) Expands Latin American Presence And Branded Generics Portfolio With Acquisition Of CFR Pharmaceuticals 5/16/2014
Pfizer Inc. (PFE) Exec Claims AstraZeneca PLC (AZN) Deal Will Not Put Lives At Risk 5/15/2014
AstraZeneca PLC (AZN) Leaves Door Ajar To Pfizer Inc. (PFE), Despite Hurdles 5/15/2014
Eurofins Shells Out $255 Million For U.S. Diagnostic Testing Company 5/14/2014
Origin Agritech Limited (SEED) Announces Receipt Of Acquisition Proposal 5/13/2014
Pfizer Inc. (PFE) Presses AstraZeneca PLC (AZN) Case As CEO Faces UK Grilling 5/13/2014
Shire Pharmaceuticals (SHPG) To Acquire Lumena Pharmaceuticals For Upfront Payment Of $260 Million In Cash 5/13/2014
Merck & Co., Inc. (MRK) Signs Sale Agreement With Santen Pharmaceutical For Merck's Ophthalmology Products In Japan And Key Markets In Europe And Asia Pacific 5/13/2014
Pfizer Inc. (PFE)'s Bid For AstraZeneca PLC (AZN) Shows That Big Pharma Is As Rotten As The Banks 5/13/2014
Merck KGaA (MKGAF.PK) Invests In Innovations For Future Growth 5/12/2014
Mallinckrodt Pharmaceuticals (MNK) And Questcor Pharmaceuticals, Inc. (Headquarters) (QCOR) Announce Early Termination Of HSR Act Waiting Period 5/12/2014
Lundbeck Inc. (LUN.CO) Swallows Up Chelsea Therapeutics, Inc. (CHTP) In Deal Worth $658 Million 5/9/2014
Taking A Swipe At Mylan Inc. (MYL), MEDA Preys On Its Own M&A Opportunities 5/8/2014
AstraZeneca PLC (AZN) Shares Back On Rise Amid Fresh Bid Speculation 5/8/2014
Despite Repeated Rebuffs, Teva Pharmaceutical Industries Limited (TEVA) Woos Cipla Ltd. With $6 Billion Offer 5/8/2014
Pfizer Inc. (PFE) Execs Claim AstraZeneca PLC (AZN) Takeover Could Improve R&D 5/7/2014
Pfizer Inc. (PFE) Hints At Potential Hostile Move For AstraZeneca PLC (AZN) 5/7/2014
Merck & Co., Inc. (MRK) May Use Bayer AG (BAYZF) Cash To Hunt For Companies With Promising Experimental Drugs 5/7/2014
Bayer AG (BAYZF) Finally Bags Merck & Co., Inc. (MRK)'s Consumer Biz For $14.2 Billion 5/7/2014
FORMA Therapeutics, Inc. Acquires Covalent Chemistry Platform From Netherlands Cancer Institute (NCI) 5/5/2014
Novartis AG (NVS) Abandons $600 Million Purchase Of Gamida Cell Ltd. 5/5/2014
AstraZeneca PLC (AZN) Calls Pfizer Inc. (PFE) Takeover Bid "Inadequate," Nixes Sweetened $106 Billion Offer 5/5/2014
Shire Pockets A Promising Pipeline In $75 Million Plus Fibrotech Buyout Deal 5/2/2014
Reckitt Benckiser Plc (RB.L) Says No Longer In Talks With Merck & Co., Inc. (MRK) 5/1/2014
Amgen (AMGN), AbbVie (ABBV) Seen As Possible White Knights For AstraZeneca PLC (AZN) 5/1/2014
Bayer AG (BAYZF) Offers To Swap Animal Health Unit, Cash For Merck & Co., Inc. (MRK)'s $14 Billion OTC Unit 5/1/2014
GlaxoSmithKline (GSK) Distances Itself From Bid For Rival AstraZeneca PLC (AZN) 5/1/2014
Sanofi (France) (SAN.PA) Explores $7 Billion-Plus Sale Of Mature Drug Portfolio Amid Pharma M&A Resurgence 5/1/2014
Bayer AG (BAYZF) May Sell $10 Billion Plastics Unit To Focus On Health 4/30/2014
Healthcap IV Is Committed To Vote In Support Of TopoTarget A/S’s Proposed Merger With BioAlliance Pharma 4/29/2014
Allergan Inc. (AGN) Contacts Sanofi (France) (SAN.PA), Johnson & Johnson (JNJ) To See If They Are Interested 4/29/2014
Mylan Inc. (MYL) Can't Take Hint, Meda AB (MEDA-A.ST) Rejects Second Takeover Offer 4/28/2014
Zogenix, Inc. (ZGNX) Unloads Sumavel® DosePro® To Endo For $85 Million Cash 4/24/2014
AstraZeneca PLC (AZN) Finally Rids Delaware Site For Approximately $44 Million 4/23/2014
GlaxoSmithKline (GSK) Pays $7.1 Billion For Novartis AG (NVS)'s Vaccine Business 4/22/2014
Beckman Coulter, Inc. (BEC) Buys Xitogen Of Suzhou 4/22/2014
Pfizer Inc. (PFE) Cautiously Approaches Strained AstraZeneca PLC (AZN) With $101 Billion Buyout Deal 4/22/2014
Fosun Pharma Ups Offer For Healthcare Chain Chindex International, Inc. (CHDX) From $369 Million To $461 Million 4/21/2014
Chindex International, Inc. (CHDX) Agrees To Higher $24/Share Bid From Insiders 4/21/2014
Actavis (ACT) And Forest Laboratories, Inc. (FRX) Receive Federal Trade Commission Second Request Under Hart-Scott-Rodino 4/18/2014
GlaxoSmithKline (GSK) To Unload 60-Acre Property In India 4/18/2014
BioAlliance Pharma And TopoTarget A/S To Merge To Form Orphan Oncology Powerhouse 4/16/2014
Novartis AG (NVS) Overtakes Pfizer Inc. (PFE) As Top Drug Company 4/16/2014
Novartis AG (NVS), Shire Weighing $1.3 Billion Offer For ThromboGenics NV (TBGNF) 4/15/2014
Chindex International, Inc. (CHDX) Announces Higher $23/Share Takeover Offer 4/14/2014
Novartis AG (NVS) To Sell Off Land For Homes While Exploring Options For Future Science Or Business Park 4/11/2014
Royal DSM In Exclusive Discussions To Acquire Aland (China) 4/9/2014
Zhejiang Conba Pays $160.5 Million For Majority Stake In Baite Pharma 4/9/2014
Sun Pharmaceutical Industries Ltd (SUNPHARMA.NS) Plans To Gradually Phase-Out Of Ranbaxy Laboratories (RANBAXY.BO)-Branded Drugs In U.S. 4/9/2014
Meda AB (MEDA-A.ST), Valeant Pharmaceuticals International (VRX) Terminate Joint Ventures 4/7/2014
Sun Pharmaceutical Industries Ltd (SUNPHARMA.NS) To Buy Struggling Ranbaxy Laboratories (RANBAXY.BO) In $3.2-Billion Landmark Transaction 4/7/2014
Roche (RHHBY) Buys Rights To ORYZON Genomics's Cancer-Suppressing Gene Drug In $521 Million+ Deal 4/7/2014
Mylan Inc. (MYL) Rumored To Be Considering Bid For Swedish Pharm Rival Meda AB (MEDA-A.ST), Meda Shares Halted 4/4/2014
Like GlaxoSmithKline (GSK), Sanofi (France) (SAN.PA) Eyes More Acquisitions, Sees Growth In Africa 4/3/2014
Charles River Laboratories (Massachusetts) And Galapagos NV (GLPG.BR) Complete Transaction 4/1/2014
PPF Group Expands In The Field Of Biotechnology And Immunotherapy 4/1/2014
Actavis (ACT) Bets $100 Million Cash OnThai Pharmaceutical Silom Medical 4/1/2014
ADI: Proposed Acquisition Of Tiziana Pharma Limited 3/31/2014
ICON Scoops Up Medical Device Firm Aptiv Solutions For $143.5 Million Cash 3/31/2014
Lupin Ltd. (LUPN.BO) Buys Mexican Drugmaker Laboratorios Grin S.A. De C.V. For Undisclosed Sum 3/28/2014
AstraZeneca PLC (AZN) Takes Full Control Of Japanese Unit, Buys Out Sumitomo Chemical Company, Ltd. For $102 Million 3/26/2014
Sanofi (France) (SAN.PA) Rumored To Join Bidders For Merck & Co., Inc. (MRK)'s Consumer Unit 3/25/2014
Evotec AG (EVTG.F) Acquires Bionamics GmbH To Accelerate "EVT Innovate" Strategy 3/24/2014
Horizon Pharma Scoops Up Vidara Therapeutics In $660 Million Buyout Move, Will Become Horizon Pharma plc.  (HZNP) 3/19/2014
Mallinckrodt Pharmaceuticals (MNK) Completes $1.4 Billion Acquisition Of Cadence Pharmaceuticals, Inc. 3/19/2014
Proteon Therapeutics, Inc., Looking Past Ill-Fated Novartis AG (NVS) Deal, Goes It Alone 3/18/2014
Gamida Cell Ltd. Gets Hefty Buyout Offer From Unknown Global Pharma Co., Is It Novartis AG (NVS)? 3/18/2014
Vectura Limited Pays A Whopping $181 Million For Activaero 3/13/2014
AstraZeneca PLC (AZN) To Sell UK Research Site, Record Charge Of $275 Million 3/12/2014
GlaxoSmithKline (GSK) Ponies Up $1 Billion To Lift Indian Stake To 75 Percent 3/10/2014
Kemira Oyj Completes The Divestment Of Chemsolutions' Formic Acid Business 3/6/2014
Debiopharm To Acquire Products Or Companies To Expand Activities At Manufacturing Facility In Martigny (Valais, Switzerland) 3/6/2014
Advanced Accelerator Applications Enters UK And Irish Nuclear Medicine Markets With The Acquisition Of Imaging Equipment Ltd 3/4/2014
Shyndec (600420.SS) Pays $49 Million For 30% Of Rongsheng Pharma 3/3/2014
Novartis AG (NVS) Chairman Rules Out Merger With Roche (RHHBY) 3/3/2014
Endo Health Solutions Inc. (ENDP) Completes Acquisition Of Paladin Labs Inc. (CC:PLB) 2/28/2014
BioTie Therapies Corp. Updates Outlook: Intends To Develop SYN120 Internally And Will Not Exercise Its Option To Acquire Neurelis Until Further Notice 2/28/2014
Shanxi Taxus Pharma Plans To Acquire California Pharma 2/28/2014
Perrigo Company (PRGO) Scoops Up Basket Of Value-Brand OTC Drugs For $51 Million Cash 2/28/2014
Watson-Marlow Pumps Group Acquires Bio Pure Technology Limited 2/27/2014
Bayer AG (BAYN.DE) Buys Dihon Pharmaceutical Group For About $680 Million To Add Traditional Chinese Medicine To Product Line 2/27/2014
Pfizer Inc. (PFE) Reveals Internal Restructuring Plans 2/27/2014
Rumor: AstraZeneca PLC (AZN) Actively Pursued Forest Laboratories, Inc. (FRX) 2/26/2014
Eli Lilly and Company (LLY) To Buy German Poultry Vaccine Maker For Undisclosed Amount 2/25/2014
Bayer AG (BAYN.DE) Clinches $2.9 Billion Deal For Norway's Algeta 2/24/2014
Andromeda Biotech Acquires DiaPep277 Rights From Teva Pharmaceutical Industries Limited (TEVA) 2/24/2014
Week in Review: Fosun Pharma And TPG Offer $369 Million For Chindex International, Inc. (CHDX) 2/24/2014
Shuanglong Tonghua Chemical Co., Ltd Acquires Jinbao Pharma For $178 Million 2/24/2014
Harbin Gloria Pharmaceuticals (002437.SZ) In $170 Million Deal To Acquire Huatuo Medical Science 2/24/2014
Teva Pharmaceutical Industries Limited (TEVA) Advances Amid Takeover Prospects 2/24/2014
Jazz Pharmaceuticals plc (JAZZ) Completes Tender Offer For Gentium S.p.A. Shares 2/21/2014
Merck KGaA (MKGAF.PK) Has Cash Ready To Pursue A Takeover Worth Billions: CEO 2/21/2014
Actavis (ACT)' Acquisition Of Forest Laboratories, Inc. (FRX) Will Expand Its Branded Drug Portfolio And Facilitate Long-Term Growth, Says Globaldata Analyst 2/20/2014
Actavis (ACT) Bags Rival, Forest Laboratories, Inc. (FRX), For $25 Billion; Forest Stock Rockets +27.52% At Market Close (February 18, 2014) 2/19/2014
Fosun Pharma, TPG Scoop Up US-Listed Chinese Healthcare Firm Chindex International, Inc. (CHDX) In $369 Million Deal 2/18/2014
Endo Health Solutions Inc. (ENDP) Announces South African Competition Act Compliance And Approval Under The Investment Canada Act In Connection With Its Proposed Acquisition Of Paladin Labs Inc. (CC:PLB) 2/18/2014
Citic Private Equity Rumored To Take Biosensors International Private 2/18/2014
CFR Pharmaceuticals Announces Exemption From The Takeover Regulation Panel ("TRP") And Confirmation That The Termination Agreement Concluded On 7 February 2014 ("Termination Agreement") Is Now Effective 2/13/2014
Debiopharm To Acquire Affinium Pharmaceuticals's Antibiotic Clinical Assets And Platform To Identify And Develop Targeted Antibiotics 2/10/2014
Suitors Eye Novartis AG (NVS)'s Vaccines Business 2/5/2014
Chiesi Farmaceutici SpA Completes Acquisition Of Cornerstone Therapeutics Inc. 2/4/2014
Dassault Systèmes SolidWorks Corp. Offers $750 Million To Acquire Accelrys Inc. (ACCL) 1/30/2014
Actavis (ACT) Announces Agreement With Zhejiang Chiral Medicine Chemicals Co., Ltd To Divest Actavis Foshan, China 1/27/2014
PharmaCell BV To Purchase Cell Therapy Production Facility From TiGenix 1/24/2014
Jazz Pharmaceuticals plc (JAZZ) Announces Minimum Tender Condition Exceeded During Initial Offering Period For Gentium S.p.A. Shares 1/23/2014
Changchun Technology Industries Pays $5 Million For Mucosis Stake 1/20/2014
Actavis (ACT) Divests Seven European Countries' Ops To Aurobindo Pharma (AUROBINDOP.BO) For $40.7 Million 1/20/2014
Shire plc Takes $650 Million Hit On Dermagraft Sale To Organogenesis Inc. 1/17/2014
China Approves Thermo Fisher Scientific (TMO), Life Technologies (LIFE) Deal With Conditions 1/16/2014



//-->